The Effect of Smoking and Non-surgical Periodontal Treatment on Gingival Crevicular Fluid Cyclophilin A and EMMPRIN Levels
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ege University
- Enrollment
- 58
- Primary Endpoint
- Change in gingival crevicular fluid EMMPRIN total amounts
Study Overview
Brief Summary
This study aimed to investigate the effect of smoking and non-surgical periodontal treatment on gingival crevicular fluid CyPA and EMMPRIN levels in patients with periodontitis. Twenty-eight patients with periodontitis (14 non-smoker and 14 smoker) and 30 control subjects (15 non-smoker and 15 smoker) were included into the study. Non-surgical periodontal treatment was applied to all periodontitis patients. Periodontal parameters and GCF CyPA and EMMPRIN levels were evaluated during 3 months following non-surgical periodontal treatment. GCF CyPA and EMMPRIN levels were analyzed by ELISA.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 29 Years to 61 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •generalized periodontitis with stage III-IV & Grade B
- •no systemic and periodontal diseases
- •smokers (minimum 10 cigarettes per day for at least ten years)
- •non-smokers (never smoked)
Exclusion Criteria
- •Systemic diseases
- •Infectious diseases
- •Pregnancy or lactating
- •Having periodontal treatment during the last 6 months
- •Having antibiotic treatment within the past 3 months
- •Former smokers
Arms & Interventions
smoker
Intervention: non-surgical periodontal treatment (Procedure)
non-smoker
Intervention: non-surgical periodontal treatment (Procedure)
Outcomes
Primary Outcomes
Change in gingival crevicular fluid EMMPRIN total amounts
Time Frame: Baseline, 1 week, 1., 3. months
GCF EMMPRIN levels were analyzed by ELISA
Change in gingival crevicular fluid CypA total amounts
Time Frame: Baseline, 1 week, 1., 3. months
GCF CyPA levels were analyzed by ELISA
Secondary Outcomes
- Change in bleeding on probing(Baseline, 1., 3. months)
- Change in probing depth(Baseline, 1., 3. months)
Investigators
Oya Turkoglu
Professor
Ege University
